Literature DB >> 29275074

Melanotic neuroectodermal tumor of infancy (MNTI) of the head and neck: A French multicenter study.

Audrey Moreau1, Louise Galmiche2, Veronique Minard-Colin3, Martin Rachwalski4, Kahina Belhous5, Daniel Orbach6, Aline Joly1, Arnaud Picard7, Natacha Kadlub8.   

Abstract

OBJECTIVES: Melanotic neuroectodermal tumor of infancy (MNTI) of the head and neck is a rare entity with uncertain clinical behavior. Radical surgical resection is the current recommended treatment, however this can cause severe aesthetic and functional sequelae. The aim of this study was to clinically characterize MNTIs and to stratify risk factors that may influence locoregional recurrence.
METHODS: A retrospective multicenter study, including 11 patients from eight centers with a confirmed diagnosis of MNTI, was conducted. Epidemiological, clinical, radiological, pathological, and immunohistochemical examinations were reviewed. A statistical analysis using a t-test was conducted to calculate parameters correlating with tumor recurrence.
RESULTS: MNTIs mainly occurred in the maxilla, with a mean age at diagnosis of 3.18 months (range: 0-6 months). Primary surgery was performed on 10 patients, with a clear margin resection on two patients. Overall recurrence rate was 27% with a survival of 100% at time of follow-up. No statistical correlation between recurrence rate, age at diagnosis, localization, resection margins, and pathological and immunohistochemical characteristics could be established.
CONCLUSION: In our study, locoregional tumor recurrence did not seem to correlate with resection margins, so a conservative surgical approach may need to be considered to avoid functional and aesthetic sequelae.
Copyright © 2017 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Benign tumor; Infancy; MNTI; Melanotic neuroectodermal tumor of infancy; Melanotic progonoma

Mesh:

Year:  2017        PMID: 29275074     DOI: 10.1016/j.jcms.2017.12.001

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  7 in total

1.  Melanotic Neuroectodermal Tumor Presenting as Endolymphatic Sac Tumor.

Authors:  Joseph Choy; Mehdi Abouzari; Hossein Mahboubi; Mark E Linskey; Hamid R Djalilian
Journal:  Ear Nose Throat J       Date:  2019-04-07       Impact factor: 1.697

2.  Melanotic Neuroectodermal Tumor of Infancy: the Use of Immunohistochemical Analysis.

Authors:  André Luca Araujo de Sousa; Wanderson Carvalho de Almeida; Jean de Pinho Mendes; Victor Angelo Martins Montalli; Antonione Santos Bezerra Pinto
Journal:  Acta Stomatol Croat       Date:  2022-06

Review 3.  Malignant Superficial Mesenchymal Tumors in Children.

Authors:  Philippe Drabent; Sylvie Fraitag
Journal:  Cancers (Basel)       Date:  2022-04-26       Impact factor: 6.575

Review 4.  Melanotic neuroectodermal tumor of infancy to the skull: case-based review.

Authors:  Florian Ebel; Florian M Thieringer; Christoph Kunz; Andreas Klein-Franke; Katrin Scheinemann; Raphael Guzman; Jehuda Soleman
Journal:  Childs Nerv Syst       Date:  2020-01-17       Impact factor: 1.475

Review 5.  Clinical and imaging features of melanotic neuro-ectodermal tumor of infancy of the maxillary bone: report of four cases and review of the literature.

Authors:  Yujiao Guo; Ying Liu; Xingang Wang; Gang Li; Guoxia Yu
Journal:  Oral Radiol       Date:  2022-07-25       Impact factor: 1.882

6.  Melanotic Neuroectodermal Tumour of Infancy - A Case Report and Review of Literature.

Authors:  Sabareesh Jakka; Indranil Deb Roy; Mohan Rangan; Satyanarayan Pandey; Anup Kumar Singh
Journal:  Ann Maxillofac Surg       Date:  2022-08-16

7.  Melanotic Neuroectodermal Tumor of Infancy: A Clinicopathological and BRAF V600E Mutation Study of 11 Cases.

Authors:  Rong-Hui Xia; Chun-Ye Zhang; Li-Zhen Wang; Yu-Hua Hu; Jing-Jing Sun; Zhen Tian; Jiang Li
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.